{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T03:22:08Z","timestamp":1778988128598,"version":"3.51.4"},"reference-count":29,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/mmr.2015.3624","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T06:58:25Z","timestamp":1429167505000},"page":"2068-2074","source":"Crossref","is-referenced-by-count":7,"title":["Conditionally replicating oncolytic adenoviral vector expressing arresten and tumor necrosis factor-related apoptosis-inducing ligand experimentally suppresses lung carcinoma progression"],"prefix":"10.3892","volume":"12","author":[{"given":"SHUDONG","family":"LI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZONGLI","family":"QI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUIJIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN","family":"HU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DONGYANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHENZHEN","family":"FENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"key20180108021926_b1-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/1759-7714.12025","article-title":"Lung cancer incidence and mortality in China, 2009","volume":"4","author":"Chen","year":"2013","journal-title":"Thoracic Cancer"},{"issue":"Suppl 8","key":"key20180108021926_b2-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0959-8049(01)00267-2","article-title":"Cancer burden in the year 2000. The global picture","volume":"37","author":"Parkin","year":"2001","journal-title":"Eur J Cancer"},{"key":"key20180108021926_b3-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1385\/ABAB:133:1:9","article-title":"Adenoviral vectors: a promising tool for gene therapy","volume":"133","author":"Ghosh","year":"2006","journal-title":"Appl Biochem Biotechnol"},{"key":"key20180108021926_b4-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/14796694.2.1.137","article-title":"Current developments in adenovirus-based cancer gene therapy","volume":"2","author":"Rein","year":"2006","journal-title":"Future Oncol"},{"key":"key20180108021926_b5-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/156800907780618301","article-title":"Conditionally replicating adenoviruses for cancer treatment","volume":"7","author":"Jounaidi","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180108021926_b6-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/0008-5472.CAN-06-3000","article-title":"Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses","volume":"67","author":"Bilsland","year":"2007","journal-title":"Cancer Res"},{"key":"key20180108021926_b7-mmr-12-02-2068","first-page":"7936","article-title":"Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis","volume":"63","author":"Lanson","year":"2003","journal-title":"Cancer Res"},{"key":"key20180108021926_b8-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-422X-6-18","article-title":"A simplified in vitro ligation approach to clone an E1B55k-deleted double-targeted conditionally-replicative adenovirus","volume":"6","author":"Haviv","year":"2009","journal-title":"Virol J"},{"key":"key20180108021926_b9-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/sj.gt.3302271","article-title":"Enhanced efficacy of Escherichia coli nitroreductase\/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector","volume":"11","author":"Chen","year":"2004","journal-title":"Gene Ther"},{"key":"key20180108021926_b10-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-4598-7-9","article-title":"Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastases","volume":"7","author":"Graat","year":"2008","journal-title":"Mol Cancer"},{"key":"key20180108021926_b11-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1158\/1078-0432.CCR-07-1265","article-title":"Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma","volume":"13","author":"Lamfers","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180108021926_b12-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bjc.6600006","article-title":"ONYX-015: mechanism of action and clinical potential of replication-selective adenovirus","volume":"86","author":"Ries","year":"2002","journal-title":"Br J Cancer"},{"key":"key20180108021926_b13-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI9762","article-title":"Replication-selective adenoviruses as oncolytic agents","volume":"105","author":"Heise","year":"2000","journal-title":"J Clin Invest"},{"key":"key20180108021926_b14-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jmir.2008.07.003","article-title":"Oncolytic viruses: A new weapon to fight cancer","volume":"39","author":"Brown","year":"2008","journal-title":"J Med Imag Rad Sci"},{"key":"key20180108021926_b15-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2007.02.002","article-title":"Oncolytic viruses in cancer therapy","volume":"254","author":"V\u00e4h\u00e4-Koskela","year":"2007","journal-title":"Cancer Lett"},{"key":"key20180108021926_b16-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2009.05.006","article-title":"E1B-55kDa-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer","volume":"285","author":"He","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180108021926_b17-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2008.07.005","article-title":"Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor","volume":"374","author":"Fan","year":"2008","journal-title":"Biochemical Biophys Res Commun"},{"key":"key20180108021926_b18-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1172\/JCI24813","article-title":"Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin","volume":"115","author":"Sudhakar","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180108021926_b19-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/cgt.2011.84","article-title":"A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy","volume":"19","author":"Chai","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"key20180108021926_b20-mmr-12-02-2068","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council of The National Academies","year":"2011","edition":"8th edition"},{"key":"key20180108021926_b21-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/hum.2011.130","article-title":"A fiber chimeric CRAd vector Ad5\/11-D24 double-armed with TRAIL and arresten for enhanced glioblastoma","volume":"23","author":"Li","year":"2012","journal-title":"Hum Gene Ther"},{"key":"key20180108021926_b22-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/cgt.2011.11","article-title":"Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells","volume":"18","author":"Kim","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"key20180108021926_b23-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3892\/ijmm.2012.998","article-title":"Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo","volume":"30","author":"Zhang","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180108021926_b24-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2009.06.066","article-title":"TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies","volume":"625","author":"Holoch","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"key20180108021926_b25-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3858\/emm.2011.43.10.065","article-title":"Preclinical studies for pharmacokinetics and biodistribution of Ad-stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy","volume":"43","author":"Kim","year":"2011","journal-title":"Exp Mol Med"},{"key":"key20180108021926_b26-mmr-12-02-2068","first-page":"2520","article-title":"Anti-angiogenic cues from vascular basement membrane collagen","volume":"60","author":"Colorado","year":"2000","journal-title":"Cancer Res"},{"key":"key20180108021926_b27-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"e51044","DOI":"10.1371\/journal.pone.0051044","article-title":"Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma","volume":"7","author":"Aikio","year":"2012","journal-title":"PLoS One"},{"key":"key20180108021926_b28-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1167\/iovs.09-3473","article-title":"FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IVC1","volume":"50","author":"Boosani","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20180108021926_b29-mmr-12-02-2068","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-11-2348","article-title":"p53 inhibits angiogenesis by inducing the production of Arresten","volume":"72","author":"Assadian","year":"2012","journal-title":"Cancer Res"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3624\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T04:20:13Z","timestamp":1515385213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,4,16]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/mmr.2015.3624"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3624","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}